Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Fatty heart
View:
Post by scarlet1967 on Aug 30, 2022 5:02pm

Fatty heart

 

This study started while ago and the status was unknown, it was recently updated as complete so I guess there were some Covid related issues for the long delay. The purpose was to evaluate the relationship between GH deficiency and fat accumulation inside the heart muscles. Obviously obesity/high levels of VAT will be causing cardiac steatosis but HIV and long term use of antivirals also disturbs glucose/fat metabolism resulting in high blood sugar/fat. That’s the thinking among others behind increased prevalence of fatty liver/heart among PLWH. So it will be interesting to know what was the conclusion. Again point is there are several ongoing studies evaluating various therapeutic benefits of Tesamorelin and some are for serious conditions such as heart attack although

ischaemic heart diseases are more common metabolic heart diseases are still very common specifically among PLWH.

 

Growth Hormone Dynamics and Cardiac Steatosis in HIV - Full Text View - ClinicalTrials.gov

Comment by stephanedodier on Aug 30, 2022 6:02pm
Thanks for sharing Scarlet,    I was wondering where was our friend Dr. Steven K. Grinspoon ...   Seriously, it's been a long time.... is M. Grinspoon still part of the THTX family ?
Comment by scarlet1967 on Aug 30, 2022 6:57pm
You are welcome, he is one of the three current advisors on the website also both he and his hospital are entitled to milestone payments when and if the NASH trial progresses so he is highly motivated to have that trial started not only financially but also because of all the hard academic work. https://www.globenewswire.com/news-release/2020/02/04/1979391/0/en/Theratechnologies-Signs-Agreements ...more  
Comment by Lee430 on Sep 01, 2022 11:52am
I do feel empathy for Dr Greenspoon as it appears a promising piece of his life’s work & hopes are withering away on the vine…Hopefully SOON Thera will show us their plan to get this indication over the finish line or sell this asset off to help support the Sort1+ platform research.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities